Section of Gastroenterology and Hepatology, West Virginia University Medicine, Morgantown, West Virginia, USA.
Division of Gastroenterology and Hepatology, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
Gastrointest Endosc. 2020 Nov;92(5):1055-1066. doi: 10.1016/j.gie.2020.04.061. Epub 2020 May 4.
Anterograde endoscopic ultrasound-guided pancreatic duct drainage (EUS-PDD) refers to transmural drainage of the main pancreatic duct via an endoprosthesis passed anterograde through the gastric (or intestinal) wall. Anterograde EUS-PDD is a rescue procedure for recalcitrant cases of benign obstructive pancreatopathy.
We conducted a dual-center retrospective chart review of 28 patients (mean age, 59 years; 50% female) who underwent attempted anterograde EUS-PDD between April 2016 and September 2019 for chronic pancreatitis (CP) (93%) or pancreaticojejunostomy stenosis (PJS) after Whipple resection (7%). The study endpoint was achievement of transpapillary/transanastomotic drainage (definitive therapy).
Gastropancreaticoenterostomy (ring drainage, definitive therapy) was successfully performed during the index procedure in the 2 patients with PJS (technical success, 100%). Clinical success was 100% in the 2 ring drainage recipients during a mean 18-month follow-up period. The remaining 26 patients with CP underwent attempted pancreaticogastrostomy (PG) with 81% technical success, 75% clinical success, and 15% adverse events (AEs). Repeat endoscopic transmural interventions were performed in the 15 patients with clinical success after PG creation. Definitive therapy transpired in all 15 patients after a median 1 repeat procedure per patient. Clinical success after definitive therapy was maintained in all 15 patients (100%) during a median 4.5-month follow-up.
In agreement with previous studies, our study showed mild to moderately high rates of technical failure (19%), clinical failure (25%), and AEs (15%) during index drainage (PG creation). Among patients with CP with both technical and clinical success after index PG creation (n = 15), 100% definitive therapy was achieved and clinical outcomes were excellent (100% clinical success, 0% AEs).
顺行内镜超声引导下胰管引流术(EUS-PDD)是指通过内镜穿过胃(或肠)壁,将内置支架顺行穿过主胰管进行透壁引流。顺行 EUS-PDD 是治疗难治性良性梗阻性胰腺炎的一种抢救方法。
我们对 2016 年 4 月至 2019 年 9 月期间因慢性胰腺炎(CP)(93%)或胰十二指肠切除术后胰肠吻合口狭窄(PJS)(7%)而行顺行 EUS-PDD 尝试的 28 例患者(平均年龄 59 岁;50%为女性)进行了双中心回顾性图表审查。研究终点是实现经乳头/经吻合口引流(确定性治疗)。
在 2 例 PJS 患者中,胃胰肠吻合术(环型引流,确定性治疗)在指数手术中成功进行(技术成功率 100%)。在平均 18 个月的随访期间,2 例接受环型引流的患者均取得了 100%的临床成功率。其余 26 例 CP 患者行胰胃吻合术(PG),技术成功率 81%,临床成功率 75%,不良事件(AE)发生率 15%。在 PG 术后临床成功的 15 例患者中,进行了内镜经壁重复干预。所有 15 例患者在中位 1 次重复治疗后均进行了确定性治疗。在中位 4.5 个月的随访中,所有 15 例患者在确定性治疗后均保持临床成功(100%)。
与之前的研究一致,我们的研究显示在指数引流(PG 术)期间,技术失败(19%)、临床失败(25%)和不良事件(15%)的发生率为中轻度偏高。在指数 PG 术后技术和临床均成功的 CP 患者(n=15)中,100%实现了确定性治疗,临床结局良好(100%临床成功率,0%不良事件)。